Target intelligence / Profile preview

Various lymphocyte surface antigens

Molecular classification
Receptor, Differentiation antigen, Surface immunoglobulin, Cluster of differentiation (CD) molecule, Membrane receptor
01

Overview

Lymphocyte surface antigens are diverse membrane-bound proteins used to identify and classify various lymphocyte types, including T cells, B cells, and NK cells[1][3][4][5]. The most prominent classification system is the Cluster of Differentiation (CD) nomenclature, designating over 370 distinct molecules with roles in immune cell recognition, activation, antigen presentation, and signaling[4][7]. These antigens serve as important diagnostic markers, therapeutic targets (notably in cancer and immune disorders), and functional regulators of immune responses. Well-known examples include CD3 (pan-T cell marker), CD19 and CD20 (B cell markers), and CD56 (NK cell marker). Their expression profiles guide both basic and clinical immunological applications, including patient selection for biologic therapies, disease monitoring, and immunophenotyping[1][3][4]. Note: To obtain structured information on a specific antigen (e.g., CD20, CD19), query using the precise molecule name. "Various lymphocyte surface antigens" is too generic for direct mapping to a singular canonical target.

Other names
lymphocyte surface markerscluster of differentiation antigensCD antigensleucocyte differentiation antigens
02

Mechanism of action

Antibody-dependent cellular cytotoxicity; Complement-mediated cell lysis; Inhibition of cell proliferation; Immune cell depletion

03

Biological functions

Immune responseCell signalingCell differentiationAntigen presentationCell-mediated cytotoxicityHumoral immunity
04

Disease associations

Cancer (e.g., leukemia, lymphoma)Autoimmune diseaseInfectionInflammation
05

Safety considerations

Off-target immune cell depletionCytokine release syndromeIncreased risk of infectionImmunosuppression
06

Interacting drugs

Rituximab (targets CD20)

3 more in the full profile.

07

Biomarkers

CD19, CD20 (for B-cell malignancies)CD3, CD4, CD8 (for T-cell subsets)CD56 (for NK cells)

Beyond the preview

Go deeper on Various lymphocyte surface antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Various lymphocyte surface antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call